Back to 
JANE STREET GROUP, LLC
JANE STREET GROUP, LLC
EPRX3 quarters
Position history for JANE STREET GROUP, LLC's holdings in EUPRAXIA PHARMACEUTICALS INC
Yes. Jane Street Group holds 329,053 shares of EPRX (Eupraxia Pharmaceuticals), worth $2.2M, as of its Q2 2026 13F filing. It increased the position from 35,210 shares in Q1 2026. Jane Street Group has held EPRX since Q4 2025, across 3 quarterly 13F filings.
Current Value
$2.2M
Current Shares
329,053
Total Value Change
+$1.9M
Total Shares Change
+299,431
Quarter-by-Quarter History
Other major holders of EPRX: BALYASNY ASSET MANAGEMENT L.P., SCOTIA CAPITAL INC.